The Molecular Oncology Program is a network of basic and applied scientists focused on understanding the molecular basis and fundamental processes associated with the biology of cancer cells. It is one of the two major science components of the Cancer Center (Cancer Biology in Animals is the other), which provides expertise and resources in molecular genetics, cell biology and biochemistry to other members of the Cancer Center. There are 41 members from more than 11 departments and centers. By design, they are primarily basic scientists; highly interactive, most of these scientists have collaborative projects with members of other Cancer Center programs. The Program is centered around two major research themes: 1) Kinase signaling and receptor crosstalks and 2) DNA damage and cell-cycle checkpoint. These themes are connected by common research interests in cellular signals and responses to environmental cues and carcinogenic assaults, with the common objective to understand the chemical, biochemical, and molecular basis of these processes. The Program goals include: 1) advancing the understanding of the molecular and chemical basis of cancer transformation and progression, 2) promoting the rapid translation of basic discoveries of cancer mechanisms to the development of potential prognostic markers and therapeutic strategies, and 3) providing molecular biology and biochemistry expertise to Cancer Center and fostering interactions with other programs to develop disease-oriented translational research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
1P30CA093373-01
Application #
6599354
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-07-01
Project End
2005-06-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Yuan, Ye; He, Yixuan; Bo, Ruonan et al. (2018) A facile approach to fabricate self-assembled magnetic nanotheranostics for drug delivery and imaging. Nanoscale 10:21634-21639
Seo, Jai Woong; Tavaré, Richard; Mahakian, Lisa M et al. (2018) CD8+ T-Cell Density Imaging with 64Cu-Labeled Cys-Diabody Informs Immunotherapy Protocols. Clin Cancer Res 24:4976-4987
Xue, Xiangdong; Huang, Yee; Bo, Ruonan et al. (2018) Trojan Horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment. Nat Commun 9:3653
Knight, Jennifer F; Sung, Vanessa Y C; Kuzmin, Elena et al. (2018) KIBRA (WWC1) Is a Metastasis Suppressor Gene Affected by Chromosome 5q Loss in Triple-Negative Breast Cancer. Cell Rep 22:3191-3205
Couto, K M; Moore, P F; Zwingenberger, A L et al. (2018) Clinical characteristics and outcome in dogs with small cell T-cell intestinal lymphoma. Vet Comp Oncol 16:337-343
Dou, John; Schmidt, Rebecca J; Benke, Kelly S et al. (2018) Cord blood buffy coat DNA methylation is comparable to whole cord blood methylation. Epigenetics 13:108-116
Xue, Xiangdong; Huang, Yee; Wang, Xinshuai et al. (2018) Self-indicating, fully active pharmaceutical ingredients nanoparticles (FAPIN) for multimodal imaging guided trimodality cancer therapy. Biomaterials 161:203-215
Ho, Pui Yan; Duan, Zhijian; Batra, Neelu et al. (2018) Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy. J Pharmacol Exp Ther 365:494-506
Zuo, Yang; Qi, Jinyi; Wang, Guobao (2018) Relative Patlak plot for dynamic PET parametric imaging without the need for early-time input function. Phys Med Biol 63:165004
McGee, Heather M; Daly, Megan E; Azghadi, Sohelia et al. (2018) Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site. Int J Radiat Oncol Biol Phys 101:1259-1270

Showing the most recent 10 out of 836 publications